- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE)
Commission Regulation (EC) No 508/1999Dangos y teitl llawn
Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin
You are here:
Pa Fersiwn
Nodweddion Uwch
- Dangos Graddfa Ddaearyddol(e.e. Lloegr, Cymru, Yr Alban aca Gogledd Iwerddon)
- Dangos Llinell Amser Newidiadau
Rhagor o Adnoddau
PDF o Fersiynau Diwygiedig
- ddiwygiedig 08/05/19990.14 MB
Legislation originating from the EU
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Mae hon yn eitem o ddeddfwriaeth sy’n deillio o’r UE
Mae unrhyw newidiadau sydd wedi cael eu gwneud yn barod gan y tîm yn ymddangos yn y cynnwys a chyfeirir atynt gydag anodiadau.Ar ôl y diwrnod ymadael bydd tair fersiwn o’r ddeddfwriaeth yma i’w gwirio at ddibenion gwahanol. Y fersiwn legislation.gov.uk yw’r fersiwn sy’n weithredol yn y Deyrnas Unedig. Y Fersiwn UE sydd ar EUR-lex ar hyn o bryd yw’r fersiwn sy’n weithredol yn yr UE h.y. efallai y bydd arnoch angen y fersiwn hon os byddwch yn gweithredu busnes yn yr UE. EUR-Lex Y fersiwn yn yr archif ar y we yw’r fersiwn swyddogol o’r ddeddfwriaeth fel yr oedd ar y diwrnod ymadael cyn cael ei chyhoeddi ar legislation.gov.uk ac unrhyw newidiadau ac effeithiau a weithredwyd yn y Deyrnas Unedig wedyn. Mae’r archif ar y we hefyd yn cynnwys cyfraith achos a ffurfiau mewn ieithoedd eraill o EUR-Lex. The EU Exit Web Archive legislation_originated_from_EU_p3
Changes over time for: ANNEX III
Changes to legislation:
This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
ANNEX IIIU.K.LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED
1.Anti-infectious agentsU.K.
1.1.ChemotheurapeuticsU.K.
1.1.2.BenzenesulphonamidesU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Clorsulon | Clorsulon | Bovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
| 150 μg/kg | Liver | ||||
| 400 μg/kg | Kidney |
1.2.AntibioticsU.K.
1.2.1.Beta-lactamase inhibitorsU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Clavulanic acid | Clavulanic acid | Bovine, ovine | 200 μg/kg | Milk | Provisional MRLs expire on 1 July 1999 |
| Bovine, ovine, porcine | 200 μg/kg | Muscle | |||
| 200 μg/kg | Fat | ||||
| 200 μg/kg | Liver | ||||
| 200 μg/kg | Kidney |
1.2.2.MacrolidesU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Erythromycin | MRLs apply to all microbiological active residues expressed as erythromycin equivalent | Bovine, ovine | 40 μg/kg | Milk | Provisional MRLs expire on 1 June 2000 |
| Bovine, ovine, porcine, poultry | 400 μg/kg | Muscle | |||
| 400 μg/kg | Fat | ||||
| 400 μg/kg | Liver | ||||
| 400 μg/kg | Kidney | ||||
| Poultry | 200 μg/kg | Eggs | |||
| Josamycin | Josamycin | Chicken | 200 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
| 200 μg/kg | Fat | ||||
| 200 μg/kg | Liver | ||||
| 400 μg/kg | Kidney | ||||
| 200 μg/kg | Eggs |
1.2.5.AminoglycosidesU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Aminosidine | Aminosidine | Bovine, porcine, rabbits, chicken | 500 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
| 1 500 μg/kg | Liver | ||||
| 1 500 μg/kg | Kidney | ||||
| Apramycin | Apramycin | Bovine | 1 000 μg/kg | Muscle | Provisional MRLs expire on 1 July 1999 |
| For use in non-lactating cattle only | 1 000 μg/kg | Fat | |||
| 10 000 μg/kg | Liver | ||||
| 20 000 μg/kg | Kidney | ||||
| Porcine | 1 000 μg/kg | Muscle | |||
| 1 000 μg/kg | Skin and fat | ||||
| 1 000 μg/kg | Liver | ||||
| 5 000 μg/kg | Kidney | ||||
| Dihydrostreptomycin | Dihydrostreptomycin | Bovine, ovine | 200 μg/kg | Milk | Provisional MRLs expire on 1 June 2000 |
| Bovine, ovine, porcine, poultry | 500 μg/kg | Muscle | |||
| 500 μg/kg | Fat | ||||
| 500 μg/kg | Liver | ||||
| 1 000 μg/kg | Kidney | ||||
| Gentamicin | Gentamicin | Bovine | 100 μg/kg | Milk | Provisional MRLs expire on 1 June 2000 |
| Bovine, porcine | 100 μg/kg | Muscle | |||
| 100 μg/kg | Fat | ||||
| 200 μg/kg | Liver | ||||
| 1 000 μg/kg | Kidney | ||||
| Neomycin (including framycetin) | Neomycin | Bovine, ovine, caprine | 500 μg/kg | Milk | Provisional MRLs expire on 1 June 2000 |
| Bovine, ovine, caprine, porcine, chicken, turkey, duck | 500 μg/kg | Muscle | |||
| 500 μg/kg | Fat | ||||
| 500 μg/kg | Liver | ||||
| 5 000 μg/kg | Kidney | ||||
| Chicken | 500 μg/kg | Eggs | |||
| Spectinomycin | Spectinomycin | Bovine | 200 μg/kg | Milk | Provisional MRLs expire on 1 July 2000 |
| Bovine, porcine, poultry | 300 μg/kg | Muscle | |||
| 500 μg/kg | Fat | ||||
| 2 000 μg/kg | Liver | ||||
| 5 000 μg/kg | Kidney | ||||
| Streptomycin | Streptomycin | Bovine, ovine | 200 μg/kg | Milk | Provisional MRLs expire on 1 June 2000 |
| Bovine, ovine, porcine, poultry | 500 μg/kg | Muscle | |||
| 500 μg/kg | Fat | ||||
| 500 μg/kg | Liver | ||||
| 1 000 μg/kg | Kidney |
1.2.6.QuinolonesU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Decoquinate | Decoquinate | Bovine, ovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
| 500 μg/kg | Fat | ||||
| 500 μg/kg | Liver | ||||
| 500 μg/kg | Kidney | ||||
| Enrofloxacin | Sum of enrofloxacin and ciprofloxacin | Ovine | 100 μg/kg | Muscle | Provisional MRLs expire on 1 July 1999 |
| 100 μg/kg | Fat | ||||
| 300 μg/kg | Liver | ||||
| 200 μg/kg | Kidney | ||||
| Flumequine | Flumequine | Bovine, ovine, porcine, chicken | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
| 50 μg/kg | Fat or skin and fat | ||||
| 100 μg/kg | Liver | ||||
| 300 μg/kg | Kidney | ||||
| Salmonidae | 150 μg/kg | Muscle and skin | |||
| Marbofloxacin | Marbofloxacin | Bovine | 150 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
| 50 μg/kg | Fat | ||||
| 150 μg/kg | Liver | ||||
| 150 μg/kg | Kidney | ||||
| 75 μg/kg | Milk | ||||
| Porcine | 150 μg/kg | Muscle | |||
| 50 μg/kg | Skin and fat | ||||
| 150 μg/kg | Liver | ||||
| 150 μg/kg | Kidney |
1.2.9.PolymyxinsU.K.
| Phamarcologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Colistin | Colistin | Bovine, ovine | 50 μg/kg | Milk | Provisional MRLs expire on 1 July 2000 |
| Bovine, ovine, porcine, chicken, rabbits | 150 μg/kg | Muscle | |||
| 150 μg/kg | Fat | ||||
| 150 μg/kg | Liver | ||||
| 200 μg/kg | Kidney | ||||
| Chicken | 300 μg/kg | Eggs |
1.2.10.PenicillinsU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Penethamate | Benzylpenicillin | Ovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
| 50 μg/kg | Fat | ||||
| 50 μg/kg | Liver | ||||
| 50 μg/kg | Kidney | ||||
| 4 μg/kg | Milk | ||||
| Porcine | 50 μg/kg | Muscle | |||
| 50 μg/kg | Fat | ||||
| 50 μg/kg | Liver | ||||
| 50 μg/kg | Kidney |
1.2.11.Florfenicol and related compoundsU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Florfenicol | Sum of florfenicol and its metabolites measured as florfenicol-amine | Fish | 1 000 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1 July 2001 |
2.Antiparasitic agentsU.K.
2.1.Agents acting against endoparasitesU.K.
2.1.2.Benzimidazoles and pro-benzimidazolesU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Albendazole sulphoxide | Sum of albendazole, albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole | Bovine, ovine | 100 μg/kg | Milk | Provisional MRLs expire on 1 January 2000 |
| Bovine, ovine, pheasant | 100 μg/kg | Muscle | |||
| 100 μg/kg | Fat | ||||
| 1 000 μg/kg | Liver | ||||
| 500 μg/kg | Kidney | ||||
| Netobimin | Sum of netobimin and albendazole and metabolites of albendazole measured as 2-amino- benzimidazole sulphone | Bovine, ovine, caprine | 100 μg/kg | Muscle | Provisional MRLs expire on 31 July 1999 |
| 100 μg/kg | Fat | ||||
| 1 000 μg/kg | Liver | ||||
| 500 μg/kg | Kidney | ||||
| 100 μg/kg | Milk |
2.2.Agents acting against ectoparasitesU.K.
2.2.1.FormamidinesU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Amitraz | Sum of amitraz and all metabolites containing the 2,4-DMA moeity, expressed as amitraz | Bees | 200 μg/kg | Honey | Provisional MRLs expire on 1 July 1999 |
2.2.2.Iminophenyl thiazolidine derivativeU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Cymiazole | Cymiazole | Bees | 1 000 μg/kg | Honey | Provisional MRLs expire on 1 July 1999 |
2.2.3.Pyretrin and pyrethroidsU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Cyfluthrin | Cyfluthrin | Bovine | 10 μg/kg | Muscle | Provisional MRLs expire on 1 January 2001 |
| 50 μg/kg | Fat | ||||
| 10 μg/kg | Liver | ||||
| 10 μg/kg | Kidney | ||||
| 20 μg/kg | Milk | ||||
| Further provisions in Council Directive 94/29/EC are to be observed (OJ L 189, 23.7.1994, p. 67) |
2.2.4.OrganophosphatesU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Azamethiphos | Azamethiphos | Salmonidae | 100 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1 June 1999 |
2.2.5.Acyl urea derivatesU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Teflubenzuron | Teflubenzuron | Salmonidae | 500 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1 July 1999 |
2.3.Agents acting against endo- and ectoparasitesU.K.
2.3.1.AvermectinsU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Moxidectin | Moxidectin | Equidae | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
| 500 μg/kg | Fat | ||||
| 100 μg/kg | Liver | ||||
| 50 μg/kg | Kidney |
3.Agents acting on the nervous systemU.K.
3.2.Agents acting on the autonomic nervous systemU.K.
3.2.1.β 2 sympathomimetic agentsU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Clenbuterol hydrochloride | Clenbuterol | Bovine | 0,1 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
| Indication: solely for tocolysis in parturient cows | 0,5 μg/kg | Liver | |||
| 0,5 μg/kg | Kidney | ||||
| 0,05 μg/kg | Milk | ||||
| Equidae | 0,1 μg/kg | Muscle | |||
| Indications: tocolysis and the treatment of respiratory ailments | 0,5 μg/kg | Liver | |||
| 0,5 μg/kg | Kidney |
5.Anti-inflammatory agentsU.K.
5.1.Nonsteroidal anti-inflammatory agentsU.K.
5.1.1.Arylpropionic acid derivativeU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Carprofen | Carprofen | Bovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
| 500 μg/kg | Fat | ||||
| 1 000 μg/kg | Liver | ||||
| 1 000 μg/kg | Kidney | ||||
| Equidae | 50 μg/kg | Muscle | |||
| 100 μg/kg | Fat | ||||
| 1 000 μg/kg | Liver | ||||
| 1 000 μg/kg | Kidney |
5.1.2.Enolic acid derivatesU.K.
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Meloxicam | Meloxicam | Bovine | 25 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
| 60 μg/kg | Liver | ||||
| 35 μg/kg | Kidney |
Options/Help
Print Options
PrintThe Whole Regulation
PrintThis Annex only
Mae deddfwriaeth ar gael mewn fersiynau gwahanol:
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE): Mae'r wreiddiol version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Gweler y wybodaeth ychwanegol ochr yn ochr â’r cynnwys
Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Dewisiadau Agor
Dewisiadau gwahanol i agor deddfwriaeth er mwyn gweld rhagor o gynnwys ar y sgrin ar yr un pryd
Rhagor o Adnoddau
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
- y PDF print gwreiddiol y fel adopted version that was used for the EU Official Journal
- rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
- pob fformat o’r holl ddogfennau cysylltiedig
- slipiau cywiro
- dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Llinell Amser Newidiadau
Mae’r llinell amser yma yn dangos y fersiynau gwahanol a gymerwyd o EUR-Lex yn ogystal ag unrhyw fersiynau dilynol a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig.
Cymerir dyddiadau fersiynau’r UE o ddyddiadau’r dogfennau ar EUR-Lex ac efallai na fyddant yn cyfateb â’r adeg pan ddaeth y newidiadau i rym ar gyfer y ddogfen.
Ar gyfer unrhyw fersiynau a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig, bydd y dyddiad yn cyd-fynd â’r dyddiad cynharaf y daeth y newid (e.e. ychwanegiad, diddymiad neu gyfnewidiad) a weithredwyd i rym. Am ragor o wybodaeth gweler ein canllaw i ddeddfwriaeth ddiwygiedig ar Ddeall Deddfwriaeth.
Rhagor o Adnoddau
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
- y PDF print gwreiddiol y fel adopted fersiwn a ddefnyddiwyd am y copi print
- slipiau cywiro
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys
- rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
- manylion rhoi grym a newid cyffredinol
- pob fformat o’r holl ddogfennau cysylltiedig
- dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Mae’r holl gynnwys ar gael dan Drwydded Llywodraeth Agored v3.0 ac eithrio ble nodir yn wahanol. Yn ychwanegol mae’r safle hwn â chynnwys sy’n deillio o EUR-Lex, a ailddefnyddiwyd dan delerau Penderfyniad y Comisiwn 2011/833/EU ar ailddefnyddio dogfennau o sefydliadau’r UE. Am ragor o wybodaeth gweler ddatganiad cyhoeddus Swyddfa Gyhoeddiadau’r UE ar ailddefnyddio.